Abstract

Dysphagia is a common and severe toxicity after oncological treatment of head and neck cancer (HNC). The study aim was to investigate relationships between patient-reported dysphagia and clinically measured swallowing function in HNC after modern curative radiotherapy with or without chemotherapy to identify possible alarm symptoms for clinically manifest dysphagia. Patients with tumors of the tonsil, base of tongue, hypopharynx, and larynx treated in 2007–2015 were assessed for dysphagia post-treatment by telephone interview and videofluoroscopy (VFS). A study-specific categorized symptom score was used to determine patient-reported dysphagia (DESdC = presence of Drinking, Eating, Swallowing difficulties, and Coughing when eating/drinking (any combination); scores between 0 and 4 with 0 = no symptom); the penetration–aspiration scale (PAS) to determine swallowing function by VFS. Swallowing difficulties were defined as DESdC ≥ 1 and PAS ≥ 2. Relationships between clinically relevant cut-offs for DESdC and PAS were determined by Pearson’s correlation coefficient (Pr). Swallowing difficulties according to DESdC were reported by 89% of the patients and according to PAS by 60% at a median of 7 months post-treatment. Averaged correlations between DESdC score 1/2/3/4 and PAS were 0.16/0.10/0.27/0.18. Almost one in two patients with DESdC score ≥3 had severe swallowing difficulties according to PAS. Correlations between individual DESdC:s were highest for swallowing and eating (Pr = 0.53) and lowest for swallowing and coughing (Pr = 0.11). Our data suggest that if a patient reports having swallowing difficulties, it is likely that he or she also has eating difficulties but not necessarily coughing problems when eating/drinking. However, if all these three symptoms are reported, it is likely that the patient will present with moderate or severe impaired swallowing function according to PAS and thus should be referred for further evaluation and treatment.

Highlights

  • Dysphagia is the most common long-term side effect of radiation therapy (RT) for head and neck cancer (HNC) [1]

  • We explored correlations between Patient-reported outcomes (PRO) information on dysphagia and clinical outcome measures regarding swallowing impairment following nonsurgical treatment of HNC

  • We found the highest correlations between three or more patient-reported symptoms and penetration–aspiration scale (PAS) in HNC patients 7 months after oncological treatment

Read more

Summary

Introduction

Dysphagia is the most common long-term side effect of radiation therapy (RT) for head and neck cancer (HNC) [1]. Radiation-induced dysphagia affects more than 50% of HNC patients [2], making it a dose-limiting toxicity [3]. Swallowing difficulties are associated with high risk of aspiration pneumonia, malnutrition, and dehydration [4]. The patients’ general health as well as quality of life (QoL) is affected [5, 6]. Maintaining swallowing ability is, of great importance [1]. In the light of this, research is focused on finding predictors of post-treatment dysphagia, developing treatment regimens with reduced toxicity, and preventive swallowing interventions.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call